Vaccines

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

A typical vaccine takes around 10 to 12 years to reach the market. A key question: “Where should we base production?”

Nominations are now open for The Medicine Maker 2021 Power List.

GlaxoSmithKline has launched a vaccine awareness campaign in the USA as immunization rates drop amidst the pandemic.

Virus-based vaccines were the first foray into immunization, but the field has had to move on and embrace new approaches.

Drug development needs to move more rapidly, but not at the expense of safety.

In December, The Medicine Maker will showcase the top technologies to have been released throughout 2020. Nominations are now open.

As the world grasps the severity of the ongoing pandemic, we must ask how we can accelerate vaccine development safely.